Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRB | P24530 | 20/20 | 0.69 |
| ▸ | EDNRA | P25101 | 20/20 | 0.69 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.60 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.60 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8021756 | 0.82 | EDNRB (0.86) | EDNRBEDNRANR1I2KCNE1KCNQ1 | |
| Darusentan SCHEMBL795084 | 0.82 | EDNRB (1.00) | EDNRBEDNRANR1I2KCNE1KCNQ1 | |
| Darusentan SCHEMBL1068546 | 0.82 | EDNRB (1.00) | EDNRBEDNRANR1I2KCNE1KCNQ1 | |
| SCHEMBL7934042 | 0.78 | EDNRB (1.00) | EDNRBEDNRANR1I2KCNE1KCNQ1 | |
| SCHEMBL13066899 | 0.78 | EDNRB (0.86) | EDNRBEDNRANR1I2KCNE1KCNQ1 | |
| SCHEMBL795620 | 0.76 | EDNRB (0.63) | EDNRBEDNRANR1I2KCNE1KCNQ1 | |
| SCHEMBL7673723 | 0.76 | EDNRB (0.63) | EDNRBEDNRANR1I2KCNE1KCNQ1 | |
| SCHEMBL7398261 | 0.75 | EDNRB (0.73) | EDNRBEDNRANR1I2KCNE1KCNQ1 | |
| SCHEMBL8005606 | 0.75 | EDNRB (0.61) | EDNRBEDNRANR1I2KCNE1KCNQ1 | |
| Ambrisentan SCHEMBL20769813 | 0.75 | EDNRB (1.00) | EDNRBEDNRANR1I2KCNE1KCNQ1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6448248-B1 | ENDOTHELIN IS INVOLVED IN A NUMBER OF ILLNESSES INCLUDING: HYPERTENSION, ACUTE MYOCARDIAL INFARCT, PULMONARY HYPERTENSION, RAYNAUD'S SYNDROME, CEREBRAL VASOSPASMS, STROKE, BENIGN PROSTATE HYPERTROPHY, ATHEROSCLEROSIS AND ASTHMA | ABBOTT LABORATORIES | 2002-09-10 | — | — | US | disclosed |
| EP-0946524-A1 | HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES, THE PRODUCTION AND USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS | BASF AKTIENGESELLSCHAFT (DE) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998027070-A1 | HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES, THE PRODUCTION AND USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS | BASF AKTIENGESELLSCHAFT (DE) | 1998-06-25 | — | — | WO | disclosed |